Advaxis
ADXS
$0.56
Share price
4.62%
Change (1 day)
-41.58%
Change (1 year)
Categories
P/S ratio for Advaxis (ADXS)
P/S ratio as of May 2024 (TTM): 198
According to Advaxis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 198.211. At the end of 2023 the company had a P/S ratio of 33.0.
P/S ratio history for Advaxis from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 33.0 | 1356.08% |
| 2022 | 2.26 | -64.98% |
| 2021 | 6.46 | -37.41% |
| 2020 | 10.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | 0.0031 | -100.00% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | 374 | 88.67% | 🇺🇸 USA |
 Heska Corporation
HSKA | 5.14 | -97.41% | 🇺🇸 USA |